Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 5th October 2022
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zoetis completes acquisition of Jurox Animal Health
“Jurox’s portfolio plays to the strengths of our core business and will be a complementary fit with the solutions we deliver to veterinary professionals, livestock producers and pet owners" - Stephanie Armstrong, Zoetis.
Jurox is a leading provider of livestock and companion animal products.

Zoetis Ltd has completed its acquisition of Jurox, an Australian animal health firm that provides a wide range of veterinary medicines for livestock and companion animals.

Based in Hunter's Valley, New South Wales, Jurox develops and manufactures more than 150 products in areas such as parasiticides, anti-infectives, anaesthesia, cardiology, and animal reproduction.

Jurox products are currently distributed throughout Australia, the US and more than 20 other countries across the globe and include the surgical induction agent, Alfaxan. 

In a press release, Zoetis said the acquisition will bring an increased range of products, with potential for greater global expansion, future growth opportunities and insights into the animal health market. 

Commenting on the acquisition, Stephanie Armstrong, Zoetis senior vice president, said: “Jurox’s portfolio plays to the strengths of our core business and will be a complementary fit with the solutions we deliver to veterinary professionals, livestock producers and pet owners. 

"With Zoetis’ global sales and regulatory expertise in more than 45 direct markets, we look forward to expanding the impact and reach of the entire Jurox portfolio here in the UK and Ireland.” 
 
Richard Beckwith, Jurox Country manager UK & Ireland, added: “Jurox and Zoetis share similar beliefs about the important role animal health plays for the world, as well as the high standards we must keep to bringing meaningful solutions to our customers.

“We look forward to the future Jurox and Zoetis can build together in the UK and around the world.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.